121 related articles for article (PubMed ID: 38286618)
1. Combination pharmacological therapy targeting multiple mechanisms of sleep apnoea: a randomised controlled cross-over trial.
Sands SA; Collet J; Gell LK; Calianese N; Hess LB; Vena D; Azarbarzin A; Bertisch SM; Landry S; Thomson L; Joosten SA; Hamilton GS; Edwards BA
Thorax; 2024 Feb; 79(3):259-268. PubMed ID: 38286618
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Combination of Atomoxetine and Oxybutynin on OSA Endotypic Traits.
Taranto-Montemurro L; Messineo L; Azarbarzin A; Vena D; Hess LB; Calianese NA; White DP; Wellman A; Sands SA
Chest; 2020 Jun; 157(6):1626-1636. PubMed ID: 32006590
[TBL] [Abstract][Full Text] [Related]
3. The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.
Taranto-Montemurro L; Messineo L; Sands SA; Azarbarzin A; Marques M; Edwards BA; Eckert DJ; White DP; Wellman A
Am J Respir Crit Care Med; 2019 May; 199(10):1267-1276. PubMed ID: 30395486
[No Abstract] [Full Text] [Related]
4. Drug therapy for obstructive sleep apnoea in adults.
Mason M; Welsh EJ; Smith I
Cochrane Database Syst Rev; 2013 May; (5):CD003002. PubMed ID: 23728641
[TBL] [Abstract][Full Text] [Related]
5. Acetazolamide improves loop gain but not the other physiological traits causing obstructive sleep apnoea.
Edwards BA; Sands SA; Eckert DJ; White DP; Butler JP; Owens RL; Malhotra A; Wellman A
J Physiol; 2012 Mar; 590(5):1199-211. PubMed ID: 22219335
[TBL] [Abstract][Full Text] [Related]
6. Atomoxetine and fesoterodine combination improves obstructive sleep apnoea severity in patients with milder upper airway collapsibility.
Messineo L; Taranto-Montemurro L; Calianese N; Gell LK; Azarbarzin A; Labarca G; Vena D; Yang HC; Wang TY; Wellman A; Sands SA
Respirology; 2022 Nov; 27(11):975-982. PubMed ID: 35811347
[TBL] [Abstract][Full Text] [Related]
7. Drug therapy for obstructive sleep apnoea in adults.
Smith I; Lasserson TJ; Wright J
Cochrane Database Syst Rev; 2006 Apr; (2):CD003002. PubMed ID: 16625567
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility.
Schweitzer PK; Maynard JP; Wylie PE; Emsellem HA; Sands SA
Sleep Breath; 2023 May; 27(2):495-503. PubMed ID: 35551600
[TBL] [Abstract][Full Text] [Related]
9. Effects of the combination of atomoxetine and oxybutynin in Japanese patients with obstructive sleep apnoea: A randomized controlled crossover trial.
Kinouchi T; Terada J; Sakao S; Koshikawa K; Sasaki T; Sugiyama A; Sato S; Sakuma N; Abe M; Shikano K; Hayama N; Shiko Y; Ozawa Y; Ikeda S; Suzuki T; Tatsumi K
Respirology; 2023 Mar; 28(3):273-280. PubMed ID: 36184258
[TBL] [Abstract][Full Text] [Related]
10. Effect of acetazolamide on obstructive sleep apnoea in highlanders: protocol for a randomised, placebo-controlled, double-blinded crossover trial.
Tan L; Furian M; Li T; Tang X
BMJ Open; 2022 Mar; 12(3):e057113. PubMed ID: 35256446
[TBL] [Abstract][Full Text] [Related]
11. One Month Dosing of Atomoxetine plus Oxybutynin in Obstructive Sleep Apnea: A Randomized, Placebo-controlled Trial.
Aishah A; Loffler KA; Toson B; Mukherjee S; Adams RJ; Altree TJ; Ainge-Allen HW; Yee BJ; Grunstein RR; Carberry JC; Eckert DJ
Ann Am Thorac Soc; 2023 Apr; 20(4):584-595. PubMed ID: 36538809
[No Abstract] [Full Text] [Related]
12. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.
Mason M; Cates CJ; Smith I
Cochrane Database Syst Rev; 2015 Jul; (7):CD011090. PubMed ID: 26171909
[TBL] [Abstract][Full Text] [Related]
13. Acetazolamide Reduces Blood Pressure and Sleep-Disordered Breathing in Patients With Hypertension and Obstructive Sleep Apnea: A Randomized Controlled Trial.
Eskandari D; Zou D; Grote L; Hoff E; Hedner J
J Clin Sleep Med; 2018 Mar; 14(3):309-317. PubMed ID: 29510792
[TBL] [Abstract][Full Text] [Related]
14. Combination of atomoxetine with the novel antimuscarinic aroxybutynin improves mild to moderate OSA.
Rosenberg R; Abaluck B; Thein S
J Clin Sleep Med; 2022 Dec; 18(12):2837-2844. PubMed ID: 35975547
[TBL] [Abstract][Full Text] [Related]
15. Myofunctional therapy (oropharyngeal exercises) for obstructive sleep apnoea.
Rueda JR; Mugueta-Aguinaga I; Vilaró J; Rueda-Etxebarria M
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013449. PubMed ID: 33141943
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory medications for obstructive sleep apnoea in children.
Kuhle S; Hoffmann DU; Mitra S; Urschitz MS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD007074. PubMed ID: 31978261
[TBL] [Abstract][Full Text] [Related]
17. The noradrenergic agent reboxetine plus the antimuscarinic hyoscine butylbromide reduces sleep apnoea severity: a double-blind, placebo-controlled, randomised crossover trial.
Lim R; Messineo L; Grunstein RR; Carberry JC; Eckert DJ
J Physiol; 2021 Sep; 599(17):4183-4195. PubMed ID: 34174090
[TBL] [Abstract][Full Text] [Related]
18. Effect of acetazolamide and autoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude: a randomized controlled trial.
Latshang TD; Nussbaumer-Ochsner Y; Henn RM; Ulrich S; Lo Cascio CM; Ledergerber B; Kohler M; Bloch KE
JAMA; 2012 Dec; 308(22):2390-8. PubMed ID: 23232895
[TBL] [Abstract][Full Text] [Related]
19. Different antimuscarinics when combined with atomoxetine have differential effects on obstructive sleep apnea severity.
Aishah A; Lim R; Sands SA; Taranto-Montemurro L; Wellman A; Carberry JC; Eckert DJ
J Appl Physiol (1985); 2021 May; 130(5):1373-1382. PubMed ID: 33734828
[TBL] [Abstract][Full Text] [Related]
20. The norepinephrine reuptake inhibitor reboxetine alone reduces obstructive sleep apnea severity: a double-blind, placebo-controlled, randomized crossover trial.
Altree TJ; Aishah A; Loffler KA; Grunstein RR; Eckert DJ
J Clin Sleep Med; 2023 Jan; 19(1):85-96. PubMed ID: 36004739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
